Welcome to our weekly newsletter, check out the highlights from legalcommunity.ch’s newsroom. · Kellerhals Carrard advised Lakera – a AI Swiss startup founded by entrepreneurs David Haber, Matthias Kraft, and Mateo Rojas-Carulla – as well as
Search Results for: vischer
Vischer advises Oculis Holding, as the globally active biopharmaceutical company announced the pricing of offerings for an aggregate of 5,432,098 of its ordinary shares. The stocks value at $20.25 per unit, for total gross proceeds of USD 110
Swedish trading company Bufab Group completed the acquisition of Novia Group – a German-based provider of global sourcing solutions and engineering services operating across Germany, Switzerland, China, and Vietnam – from the German investment company Family Trust.
Vischer advised globally active asset manager Blue Owl on an up to USD 500 million term loan facility for Madrigal Pharmaceuticals, a biopharmaceutical company specialised in therapeutics for metabolic dysfunction-associated steatohepatitis. The Vischer team Adrian Dö
Kevin M. Hubacher (pictured) is Vischer’s latest partnership addition, effective October 1, 2025. The profile Moving from MLL Legal, Hubacher is an expert in M&A/private equity transactions, venture capital investments, restructurings and corporate
Vischer advised Proteomedix, a Swiss biotech subsidiary of Onconetix, on a licensing agreement with Swedish pancreatic cancer diagnostics company Immunovia. The agreement Under the terms of the agreement, Proteomedix will supply Immunovia with master
Hello everyone, welcome to our weekly newsletter, Signed Sealed Weekend. Bär & Karrer advised ETH Zurich throughout enactment of a revised policy for the insitute’s spin-offs and start-ups, encompassing a dedicated Equity and
Vischer advised Medartis, an SIX-listed orthopedic company with headquarters in Basel specialising in head and extremity surgery, on its acquisition of the remaining 53% of Geneva-based KeriMedical. Pursuant to the deal, Medartis becomes the sole owner
Vischer advised selling part Carauktion in connection with AutoScout24’s take-over of the C2B business, developed jointly with Carauktion itself. Pursuant to the deal – which includes the C2B auction platform – the “AutoScout24
Vischer advised Schivo on its acquisition of Mecaplast, a Swiss manufacturer of high-precision injection-moulded plastics, metals and ceramics for the medical device and life sciences sectors. Schivo – the buyer – is a medtech contract developer and
